Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - EPA:GBT - FR0000032526 - Common Stock

15.88 EUR
+0.5 (+3.25%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

4

Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 60 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of GBT get a neutral evaluation. Nothing too spectacular is happening here. GBT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

GBT had positive earnings in the past year.
GBT had a positive operating cash flow in the past year.
GBT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years GBT had a positive operating cash flow.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

GBT has a Return On Assets of 0.76%. This is comparable to the rest of the industry: GBT outperforms 40.98% of its industry peers.
GBT's Return On Equity of 2.06% is in line compared to the rest of the industry. GBT outperforms 40.98% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.17%, GBT is doing worse than 63.93% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for GBT is below the industry average of 8.99%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.17%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 0.96%, GBT perfoms like the industry average, outperforming 40.98% of the companies in the same industry.
In the last couple of years the Profit Margin of GBT has declined.
The Operating Margin of GBT (4.23%) is worse than 63.93% of its industry peers.
GBT's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 78.03%, GBT belongs to the best of the industry, outperforming 90.16% of the companies in the same industry.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
GBT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GBT has been increased compared to 5 years ago.
GBT has a worse debt/assets ratio than last year.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

GBT has an Altman-Z score of 2.08. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.08) which is comparable to the rest of the industry.
The Debt to FCF ratio of GBT is 8.88, which is on the high side as it means it would take GBT, 8.88 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GBT (8.88) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
The Debt to Equity ratio of GBT (0.93) is worse than 81.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Altman-Z 2.08
ROIC/WACC0.46
WACC6.93%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT's Current ratio of 2.32 is fine compared to the rest of the industry. GBT outperforms 65.57% of its industry peers.
GBT has a Quick Ratio of 1.03. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.03, GBT perfoms like the industry average, outperforming 45.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.89%.
The earnings per share for GBT have been decreasing by -15.50% on average. This is quite bad
Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -2.01% in the last year.
GBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

Based on estimates for the next years, GBT will show a decrease in Earnings Per Share. The EPS will decrease by -5.56% on average per year.
The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.03, GBT can be considered very expensive at the moment.
GBT's Price/Earnings ratio is a bit cheaper when compared to the industry. GBT is cheaper than 63.93% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.89. GBT is around the same levels.
A Price/Forward Earnings ratio of 10.87 indicates a reasonable valuation of GBT.
Based on the Price/Forward Earnings ratio, GBT is valued cheaply inside the industry as 81.97% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, GBT is valued rather cheaply.
Industry RankSector Rank
PE 26.03
Fwd PE 10.87
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaply inside the industry as 93.44% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than GBT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.47
EV/EBITDA 4.11
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

GBT's earnings are expected to decrease with -10.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%

3

5. Dividend

5.1 Amount

GBT has a Yearly Dividend Yield of 2.69%.
The stock price of GBT dropped by -27.65% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.11, GBT pays a better dividend. On top of this GBT pays more dividend than 85.25% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, GBT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

GBT pays out 81.48% of its income as dividend. This is not a sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.48%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (11/14/2025, 7:00:00 PM)

15.88

+0.5 (+3.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23 2025-10-23
Earnings (Next)02-04 2026-02-04
Inst Owners15.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap200.72M
Revenue(TTM)809.67M
Net Income(TTM)7.74M
Analysts46
Price Target16.58 (4.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.96%
PT rev (3m)-40.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-70.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-6.14%
Valuation
Industry RankSector Rank
PE 26.03
Fwd PE 10.87
P/S 0.25
P/FCF 4.47
P/OCF 2.14
P/B 0.53
P/tB 0.73
EV/EBITDA 4.11
EPS(TTM)0.61
EY3.84%
EPS(NY)1.46
Fwd EY9.2%
FCF(TTM)3.55
FCFY22.36%
OCF(TTM)7.41
OCFY46.63%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.21
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.49%
ROIC 3.17%
ROICexc 3.67%
ROICexgc 4.33%
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.54%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Debt/EBITDA 3.26
Cap/Depr 66.32%
Cap/Sales 6.02%
Interest Coverage 1.61
Cash Conversion 86.9%
Profit Quality 580.05%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.08
F-Score5
WACC6.93%
ROIC/WACC0.46
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%
EBIT growth 1Y-41.57%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year61.5%
EBIT Next 3Y25.44%
EBIT Next 5Y21.78%
FCF growth 1Y183.49%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2774.75%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the ChartMill fundamental rating of GUERBET (GBT.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.


Can you provide the valuation status for GUERBET?

ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for GBT stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


How sustainable is the dividend of GUERBET (GBT.PA) stock?

The dividend rating of GUERBET (GBT.PA) is 3 / 10 and the dividend payout ratio is 81.48%.